Calretinin and calbindin D-28k delay the onset of cell death after excitotoxic stimulation in transfected P19 cells

Brain Research

Volumn 909, Issue 1-2, 2001, Pages 145-158

  D'Orlando, Cristina ^a   Fellay, Benoit ^a   Schwaller, Beat ^a   Salicio, Valérie ^a   Bloc, Alain ^b   Gotzos, Vassilis ^a   Celio, Marco R ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Calbindin D 28k; Calretinin; Cell death; Excitotoxicity; Neuroprotection; NMDA; Parvalbumin

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALCIUM ION; CALRETININ; COMPLEMENTARY DNA; EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID; PARVALBUMIN; RETINOIC ACID;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CARCINOMA CELL; CELL CLONE; CELL DIFFERENTIATION; CELL PROTECTION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DNA TRANSFECTION; LONG TERM EXPOSURE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; TERATOCARCINOMA; TIME;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CALCIUM-BINDING PROTEINS; CELL DEATH; CELL DIFFERENTIATION; CELL SIZE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACIDS; GLYCINE; IMMUNOHISTOCHEMISTRY; L-LACTATE DEHYDROGENASE; MEMBRANE POTENTIALS; MICE; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PARVALBUMINS; RECEPTORS, N-METHYL-D-ASPARTATE; TRETINOIN; TUMOR STEM CELLS;

EID: 0035800644     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02671-3     Document Type: Article

References (91)

1. The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons
2. Vulnerability of midbrain dopaminergic neurons in calbindin-D28k-deficient mice: Lack of evidence for a neuroprotective role of endogenous calbindin in MPTP-treated and weaver mice
3. Calcium-binding proteins: Selective markers of nerve cells
4. Changes in shape and motility of cells transfected with parvalbumin cDNA
5. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function
6. Calcium-binding proteins in the dentate gyrus
7. From embryonal carcinoma cells to neurons: The P19 pathway
8. Changes in parvalbumin-immunoreactive neurons in the rat hippocampus following a kainic acid lesion
9. Preservation of calretinin-immunoreactive neurons in the hippocampus of epilepsy patients with Ammon's horn sclerosis
10. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin
11. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding
12. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro
13. Regulation of excitatory transmission at hippocampal synapses by calbindin D28k
14. Glutamate neurotoxicity and diseases of the nervous system
15. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease
16. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells
17. Monitoring cytosolic calcium in parathyroid hormone target cells: Osteoblasts and renal epithelia
18. A new dominant hybrid selective marker for higher eukaryotic cells
19. Electrophysiology of glutamate neurotoxicity in vitro: Induction of a calcium-dependent extended neuronal depolarization
20. Bromo-A23187: A nonfluorescent calcium ionophore for use with fluorescent probes
21. Neuroprotective properties of calretinin against the HIV-1 gp120 toxicity
22. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity
23. Stable expression of the calbindin-D28k complementary DNA interferes with the apoptotic pathway in lymphocytes
24. Alpha-parvalbumin reduces depolarization-induced elevations of cytosolic free calcium in human neuroblastoma cells
25. Effects of calcium chelators on intracellular calcium and excitotoxicity
26. Parvalbumin is a marker of ALS-resistant motor neurons
27. Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types
28. Immunohistochemical distribution of calcium-activated neutral proteinases and endogenous CANP inhibitor in the rabbit hippocampus
29. Inhibition of the proliferative cycle and apoptotic events in WiDr cells after down-regulation of the calcium-binding protein calretinin using antisense oligodeoxynucleotides
30. Concentration- and cell type-specific effects of calbindin D28k on vulnerability of hippocampal neurons to seizure-induced injury
31. Molecular neurobiology of glutamate receptors
32. A new generation of calcium indicators with greatly improved fluorescence properties
33. Expression of the calcium-binding protein, parvalbumin, in cultured cortical neurons using a HSV-1 vector system enhances NMDA neurotoxicity
34. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders
35. Lipofection of cDNAs in the embryonic vertebrate central nervous system
36. Rat brain calbindin D28: Six domain structure and extensive amino acid homology with chicken calbindin D28
37. Calbindin-D28k-containing neurons in animal models of neurodegeneration: Possible protection from excitotoxicity
38. Calbindin D-28k: A potential neuroprotective protein
39. Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures
40. Vulnerability to calcium-induced neurotoxicity in cultured neurons expressing calretinin
41. Retinoic acid-induced neural differentiation of embryonal carcinoma cells
42. Calbindin D28K as a marker for the degeneration of the striatonigral pathway in Huntington's disease
43. Calcium chelators induce apoptosis-evidence that raised intracellular ionised calcium is not essential for apoptosis
44. The calretinin-containing mossy cells survive excitotoxic insult in the gerbil dentate gyrus. Comparison of excitotoxicity-induced neuropathological changes in the gerbil and rat
45. 2+-overload or trophic factor deprivation
46. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
47. 2+ transients of neuronal dendrites
48. Cell surface changes accompanying the neural differentiation of an embryonal carcinoma cell line
49. It is calmodulin after all! Mediator of the calcium modulation of multiple ion channels
50. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds
51. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival
52. Excitatory amino acids as a final common pathway for neurologic disorders
53. Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasis
54. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity
55. 2+ in monolayers and suspensions of various types of animal cells
56. P19 embryonal carcinoma cells
57. Isolation of male embryonal carcinoma cells and their chromosome replication patterns
58. Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells
59. Gene transfer of calbindin D28k cDNA via herpes simplex virus amplicon vector decreases cytoplasmic calcium ion response and enhances neuronal survival following glutamatergic challenge but not following cyanide
60. Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells
61. Vulnerability to excitotoxic stimuli of cultured rat hippocampal neurons containing the calcium-binding proteins calretinin and calbindin D28k
62. Selective loss of GABA neurons in area CA1 of the rat hippocampus after intraventricular kainate
63. Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?
64. Excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells
65. Pharmacological and immunological characterization of N-methyl-D-aspartate receptors in human NT2-N neurons
66. Binding kinetics of calbindin-D(28k) determined by flash photolysis of caged Ca(2+)
67. 2+ in toxic cell killing
68. 2+ homeostasis
69. Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults
70. Gene therapy effectiveness differs for neuronal survival and behavioral performance
71. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons
72. Intracellular concentration of parvalbumin in nerve cells
73. Inhibition of calcium-dependent NMDA receptor current rundown by calbindin-D28k
74. Glutamate neurotoxicity in spinal cord cell culture
75. Brainstem motoneuron pools that are selectively resistant in amyotrophic lateral sclerosis are preferentially enriched in parvalbumin: Evidence from monkey brainstem for a calcium-mediated mechanism in sporadic ALS
76. Calcium buffering and protection from excitotoxic cell death by exogenous calbindin-D28k in HEK 293 cells
77. Excitotoxic neuronal death: Mechanisms and clinical relevance
78. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms
79. Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase C-type reactions
80. Calcium dependence of toxic cell death: A final common pathway
81. Characterization of a polyclonal antiserum against the purified human recombinant calcium binding protein calretinin
82. 2+-binding properties of human recombinant calretinin-22k and calretinin
83. Nucleus subputaminalis (Ayala): The still disregarded magnocellular component of the basal forebrain may be human specific and connected with the cortical speech area
84. Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease
85. Triggering and execution of neuronal death in brain ischaemia: Two phases of glutamate release by different mechanisms
86. Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischaemia: A qualitative and quantitative sequential study
87. Glutamate receptor-mediated currents and toxicity in embryonal carcinoma cells
88. Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins
89. Cortical neurons containing somatostatin- or parvalbumin-like immunoreactivity are atypically vulnerable to excitotoxic injury in vitro
90. Expression of N-methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor genes in neuroblastoma, medulloblastoma, and other cell lines
91. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line